Asian Pacific Journal of Cancer Prevention

  • 제17권9호
  • /
  • Pages.4503-4506
  • /
  • 2016
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지

Clinical Factors Predictive of Metastases from Renal Cell Carcinomas

  • Widia, Fina (Department of Urology Faculty of Medicine University of Indonesia - Cipto Mangunkusumo Hospital) ;
  • Hamid, Agus Rizal AH (Department of Urology Faculty of Medicine University of Indonesia - Cipto Mangunkusumo Hospital) ;
  • Mochtar, Chaidir A (Department of Urology Faculty of Medicine University of Indonesia - Cipto Mangunkusumo Hospital) ;
  • Umbas, Rainy (Department of Urology Faculty of Medicine University of Indonesia - Cipto Mangunkusumo Hospital)
  • 발행 : 2016.09.01
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Lymph node and distant metastases are known as the prognostic factor in renal cell carcinoma (RCC). Clinical parameters are needed to predict metastases preoperatively. The aim of this study was to assess clinical predictive factors for lymph node and distant metastases. Materials and Methods: We collected RCC data from January 1995 until December 2015 at Cipto Mangunkusumo hospital in Jakarta. We only reviewed data that had renal cell carcinoma histopathology by operation or biopsy. Clinical information such as patient age, gender, hemoglobin (Hb), erythrocyte sedimentation rate (ESR), and tumor size (clinical T stage) were reviewed and analyzed by Chi-squre and logistic regression to establish clinical predictive value. Results: A total of 102 patients were reviewed. There were 32 (31.4%) with lymph node metastases and 27 (26.5%) with distant metastases. Age, Hb and clinical T staging were associated with nodal metastases. However, only Hb and clinical T staging were found to be associated with distant metastases. By logistic regression, we found T3-4 in clinical T-stage to be the only predictor of nodal metastases (OR 5.14; 1.87 - 14.09) and distant metastases (OR 3.42; 1.27 - .9.23). Conclusions: Clinical T-stages of T3 and T4 according to The AJCC TNM classification could be used as independent clinical predictive factors for lymph node or distant metastases in patients with RCC.

키워드

참고문헌

  1. Adibi M, Karam JA, Wood CG (2015). Reporting geographic and temporal trends in renal cell carcinoma: why is this important? Eur Urol, 67, 531-2. https://doi.org/10.1016/j.eururo.2014.10.030
  2. Belldegrun AS (2007). Renal Cell Carcinoma: Prognostic Factors and Patient Selection. European Urology Supplements, 6, 477-83. https://doi.org/10.1016/j.eursup.2007.01.016
  3. Choueiri TK, Rini B, Garcia JA, et al (2007). Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma. Ann Oncol, 18, 249-55.
  4. Cohen HT, McGovern FJ (2005). Renal-cell carcinoma. N Engl J Med, 353, 2477-90. https://doi.org/10.1056/NEJMra043172
  5. Cross BW, Johnson TV, DeRosa AB, et al (2012). Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy. Int J Surgical Oncol, 6.
  6. Ficarra V, Galfano A, Verhoest G, et al (2007). Prognostic Factors and Staging Systems for Renal Cell Carcinoma. European Urol Supplements, 6, 623-9. https://doi.org/10.1016/j.eursup.2007.03.008
  7. Furniss D, Harnden P, Ali N, et al (2008). Prognostic factors for renal cell carcinoma. Cancer Treat Rev, 34, 407-26. https://doi.org/10.1016/j.ctrv.2007.12.008
  8. Guethmundsson E, Hellborg H, Lundstam S, et al (2011). Metastatic potential in renal cell carcinomas https://doi.org/10.1016/j.eururo.2011.06.029
  9. Hutterer GC, Patard JJ, Perrotte P, et al (2007). Patients with renal cell carcinoma nodal metastases can be accurately identified: external validation of a new nomogram. Int J Cancer, 121, 2556-61. https://doi.org/10.1002/ijc.23010
  10. Karakiewicz PI, Trinh QD, Bhojani N, et al (2007). Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. Eur Urol, 51, 1616-24. https://doi.org/10.1016/j.eururo.2006.12.015
  11. Lam JS, Shvarts O, Leppert JT, et al (2005). Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol, 173, 1853-62. https://doi.org/10.1097/01.ju.0000165693.68449.c3
  12. Leibovich BC, Blute ML, Cheville JC, et al (2003). Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer, 97, 1663-71. https://doi.org/10.1002/cncr.11234
  13. Ljungberg B, Bensalah K, Canfield S, et al (2015). EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol, 67, 913-24. https://doi.org/10.1016/j.eururo.2015.01.005
  14. Ljungberg B, Campbell SC, Choi HY, et al (2011). The epidemiology of renal cell carcinoma. Eur Urol, 60, 615-21. https://doi.org/10.1016/j.eururo.2011.06.049
  15. Masuda H, Kurita Y, Suzuki K, et al (1997). Predictive value of serum immunosuppressive acidic protein for staging renal cell carcinoma: comparison with other tumour markers. Br J Urol, 80, 25-9. https://doi.org/10.1046/j.1464-410X.1997.00244.x
  16. Miyata Y, Koga S, Nishikido M, et al (2001). Relationship between serum ferritin levels and tumour status in patients with renal cell carcinoma. BJU Int, 88, 974-7.
  17. Motzer RJ, Bacik J, Mazumdar M (2004). Prognostic factors for survival of patients with stage IV renal cell carcinoma: Memorial Sloan-Kettering Cancer Center experience. Clin Cancer Res, 10, 6302-3. https://doi.org/10.1158/1078-0432.CCR-040031
  18. Motzer RJ, Mazumdar M, Bacik J, et al (1999). Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol, 17, 2530-40. https://doi.org/10.1200/JCO.1999.17.8.2530
  19. Naito S, Kinoshita H, Kondo T, et al (2013). Prognostic factors of patients with metastatic renal cell carcinoma with removed metastases: a multicenter study of 556 patients. Urol, 82, 846-51. https://doi.org/10.1016/j.urology.2013.06.035
  20. Procopio G, Verzoni E, Iacovelli R, et al (2012). Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies. Br J Cancer, 107, 1227-32. https://doi.org/10.1038/bjc.2012.327
  21. Rampersaud EN, Klatte T, Bass G, et al (2014). The effect of gender and age on kidney cancer survival: younger age is an independent prognostic factor in women with renal cell carcinoma. Urol Oncol, 32, 9-13.
  22. Sengupta S, Lohse CM, Cheville JC, et al (2006). The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma. Cancer, 106, 304-12. https://doi.org/10.1002/cncr.21617
  23. Sidharth, Luitel BR, Gupta DK, et al (2011). Pattern of renal cell carcinoma - a single center experience in Nepal. Kathmandu Univ Med J (KUMJ), 9, 185-8.
  24. Toyoda Y, Shinohara N, Harabayashi T, et al (2007). Survival and prognostic classification of patients with metastatic renal cell carcinoma of bone. Eur Urol, 52, 163-8. https://doi.org/10.1016/j.eururo.2006.10.060
  25. Umbas R, Safriadi F, Mochtar CA, et al (2015). Urologic cancer in Indonesia. Jpn J Clin Oncol, 45, 708-12. https://doi.org/10.1093/jjco/hyv066
  26. Yap NY, Ng KL, Ong TA, et al (2013). Clinical prognostic factors and survival outcome in renal cell carcinoma patients--a Malaysian single centre perspective. Asian Pac J Cancer Prev, 14, 7497-500. https://doi.org/10.7314/APJCP.2013.14.12.7497
  27. Znaor A, Lortet-Tieulent J, Laversanne M, et al (2015). International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol, 67, 519-30. https://doi.org/10.1016/j.eururo.2014.10.002